MKMetin Deniz Karakoç

Metin Deniz Karakoç

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Metin Deniz Karakoç has a total of 49 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Cross-sectional Analysis on the Prescribing and Use of Proton Pump Inhibitors: Perspectives of Both Physicians and the Public

    by Metin Deniz Karakoç, Huriye Çallı, Bennu Belinay Dikici, Utku Subay

    Objective: Proton pump inhibitors (PPIs) are widely prescribed for both prophylactic and therapeutic purposes; however, their frequent use in the community and potential long-term adverse effects have raised concerns. This study aimed to evaluate patterns of PPI prescribing and use among physicians and the general population, with an emphasis on awareness of potential risks and the rationale for use.Materials and Methods: This face-to-face, cross-sectional survey study used two separate 10-item questionnaires: one for physicians and one for members of the public. A total of 120 physicians and 310 members of the public participated in the surveys.Results: Lansoprazole was the most frequently prescribed PPI (54.2%). PPI use was significantly more common in the working-age population than in other age groups (p=0.002). Among respondents, 50.3% reported having no knowledge of the potential adverse effects of PPIs. Overall, 31.6% of the public and 21.7% of physicians believed that PPIs were overused. Inappropriate medication use was identified in 54.5% of participants. Although 41.7% of physicians stated that they generally informed their patients about the duration of treatment, only 16.7% reported providing information about the potential adverse effects of long-term use.Conclusion: Our study indicates that inappropriate PPI use is highly prevalent in the study population and is inconsistent with the principles of rational drug use. Public awareness of the risks associated with inappropriate use should be increased through structured information campaigns delivered via social media platforms and public service announcements.Keywords: Drug-related side effects, Adverse reactions, drug utilization, proton pump inhibitors, physicians' practice patterns.

  • EVALUATION OF VITAMIN AND DIETARY SUPPLEMENT USE HABITS CONCERNING ACTUAL NEEDS AND THE INFLUENCE OF THE MEDIA

    by Metin Deniz Karakoç, Demet Döndü Kasım

    Objective: In recent years, the use of vitamins and other supplements has become increasingly widespread worldwide. The aim of this study is to evaluate the habits related to vitamin and dietary supplement use among the general population. Specifically, the study investigates whether the consumption of these products corresponds to actual health needs and explores the extent to which media influence affects individuals’ decisions to use such supplements. Material and Methods: A descriptive cross-sectional survey was conducted using a structured questionnaire administered to adult participants from various demographic backgrounds. The survey included questions regarding participants’ frequency and purpose of vitamin and dietary supplement use, sources of information influencing their decisions, perceived benefits, and whether their use was based on medical advice or personal preference. Descriptive statistics were used to analyze usage patterns, and chi-square tests were performed to assess associations between demographic variables and supplement use behaviors. Results: A total of 400 individuals participated in the study. Immune support was the most common reason for use (88.9%; p˂0.0001). The most preferred place to purchase the products was found to be pharmacies (52.2%; p˂0.0001). Among male individuals, the most cited reason was brand reliability (78.7%), whereas among female participants, personal recommendation (92.2%) was the most influential factor (p

  • Open Access

    N‐Acetylcysteine Attenuates Mancozeb‐Induced Hepatorenal Injury by Modulating Oxidative Stress, Inflammatory Signaling, and Apoptotic Pathways in Rats

    by Ali Çakırlı, Metin Deniz Karakoç, Özlem Özmen, Münevver Nazlıcan Kaplan, Osman Çiftçi

    Mancozeb (MNZ), a widely used dithiocarbamate fungicide, has been associated with oxidative stress–mediated organ toxicity in nontarget species. The present study investigated the potential protective effects of N‐acetylcysteine (NAC) against MNZ‐induced hepatotoxicity and nephrotoxicity in rats. Thirty‐two adult male Wistar rats were randomly assigned to four groups: Control, NAC (200 mg/kg, i.p.), MNZ (500 mg/kg, p.o.), and MNZ + NAC for 28 days. Serum biochemical parameters, tissue oxidative status, inflammatory cytokine levels, apoptosis‐related gene expression, and histopathological alterations were evaluated in liver and kidney tissues. MNZ administration significantly elevated serum ALT, AST, GGT, bilirubin, creatinine, and urea levels compared with controls ( p < 0.05). In both liver and kidney tissues, MNZ caused a significant increase in the oxidative stress index (OSI) by elevating total oxidant status (TOS) and reducing total antioxidant status (TAS) ( p < 0.001). Pro‐inflammatory cytokines (IL‐1β, IL‐6) and the mRNA expression of TNF‐α, iNOS, COX‐2, Bax, and caspase‐3 were significantly upregulated, whereas Bcl‐2 expression and the Bcl‐2/Bax ratio were reduced. Histopathological evaluation confirmed substantial structural deterioration in both organs. NAC co‐administration significantly attenuated biochemical abnormalities, restored redox balance, modulated inflammatory and apoptotic gene expression, and markedly improved tissue architecture. These findings indicate that MNZ induces hepatorenal injury through oxidative stress–associated inflammatory and apoptotic processes, and that NAC confers significant protective effects by restoring cellular redox homeostasis and limiting downstream tissue damage.

  • ANTİBİYOTİK KOMBİNASYONLARININ AKILCI KULLANIMI VE BAKTERİYEL DİRENÇ ÜZERİNE ETKİSİ

    by Metin Deniz Karakoç, Demet Döndü Kasım

    20. yüzyılın başlarında antibiyotiklerin keşfinden bu yana, insanlık tarihi açısından kısa sayılabilecek yüz yıl gibi bir süre içinde bakteriyel dirençte hızlı ve aşırı bir artış meydana gelmiştir. Bu durum günümüzde yaşamı tehdit eden küresel bir sağlık sorununa dönüşmüştür. Antibiyotiklerin keşif kronolojisindeki ilk 50 yıl ile kıyaslandığında, sonraki 50 yılda beşerî kullanıma sunulan yeni antibiyotik sayısının belirgin şekilde azaldığı görülmektedir. Son 20 yılda ise yeni antibiyotiklerin sayısı oldukça sınırlı kalmıştır. Bu durum, antibiyotik direnciyle mücadelede daha rasyonel yaklaşımların acilen geliştirilmesi gerektiğine işaret etmektedir. Çalışmamızda, antibiyotik direncine karşı stratejiler güncel literatür ışığında kollateral duyarlılık, sinerjizma ve supresyon mekanizmaları açısından değerlendirilmiş ve antibiyotik-antibiyotik ile antibiyotik-antibiyotik dışı ilaç kombinasyonlarının olası terapötik uygulamaları olduğu sonucuna ulaşılmıştır.

  • Open Access

    Evaluation of hesperidin and taurine for mitigating letrozole-induced uterine toxicity in rats: histopathological, molecular, and biochemical insights

    by Metin Deniz Karakoç, Özlem Özmen, Münevver Nazlıcan Zengin, Osman Çiftçi

    Objectives: Letrozole (LTZ), an aromatase inhibitor, is associated with significant side effects such as uterine toxicity. This study investigated the potential of hesperidin (HSP) and taurine (TAU), both natural antioxidant molecules, to mitigate LTZ-induced uterine toxicity. Methods: A total of 48 female rats were divided into six groups and treated orally for 30 days as follows: Control (sham), LTZ (1 mg/kg), HSP (100 mg/kg), TAU (100 mg/kg), LTZ+HSP, and LTZ+TAU. Histopathological, gene expression, and biochemical analyses were conducted on uterine tissues and serum samples. Results: LTZ caused a significant decrease in serum IL-1β, IL-6, estradiol, and FSH levels (p0.05). However, HSP significantly reduced oxidative stress (p<0.05), decreased the expression of genes related to apoptosis and inflammation (p0.05). Although TAU exhibited effects similar to HSP in certain parameters, its protective efficacy was comparatively less pronounced. Conclusions: The results suggest that HSP is a promising agent for mitigating LTZ-induced uterine toxicity. However, further studies with different doses and application protocols are required to more definitively elucidate the potential effects of TAU.


  • Open Access

    Oleuropein attenuated docetaxel-induced liver and kidney toxicity in rats by modulating oxidative stress, gene expressions, and histopathological damage

    by Metin Deniz Karakoç, Ozlem Ozmen, Münevver Nazlıcan ZENGİN, Osman Çi̇ftçi̇

    Docetaxel (DTX) is a frequently used antineoplastic agent despite its dose-limiting toxic effects. Our objective was to assess the effects of oleuropein (OLE), a natural polyphenol, on DTX-induced toxicity. Thirty-two male rats were randomly assigned to four groups for a four-week treatment: Control (sham), DTX (5 mg/kg weekly, i.p.), OLE (30 mg/kg daily, p.o.), and DTX+OLE. Biochemical and gene expression analyses were performed on liver, kidney, and blood samples. Additionally, histological and immunohistochemical evaluations were conducted on the liver and kidneys. OLE reduced the DTX-induced oxidative stress index in tissues. In contrast to DTX, it decreased caspase-3 and Bax gene expressions while increasing Bcl-2 expression. Furthermore, OLE improved the ALT, AST, urea, and creatinine levels, which were impaired by DTX administration. It also reduced serum IL-6, IL-1β, and TNF-α levels, which had been elevated due to DTX. Histopathological and immunohistochemical examinations revealed that OLE administration mitigated DTX-related damage in both tissues. These findings suggest that OLE might offer protection against DTX-induced liver and kidney toxicity in rats.

  • Retrospective Analysis of Pregnant Cases in Terms of Drug-Drug interactions and Teratogenic risks

    by Metin Deniz Karakoç

    Objective: While teratogenic risks in pregnant women are frequently discussed, polypharmacy and drug-drug interactions (DDI) are topics with little known information. The aim of this study is to determine the polypharmacy status, DDI, and teratogenic risk profile during pregnancy. Method: A retrospective cohort study was conducted covering the year 2023 on pregnant women who were referred for pharmacology consultation due to a history of drug use. Investigation of DDI was performed through the Micromedex and Medscape online query modules. Results: It was found that 113 pregnant women used a total of 71 different active ingredient drugs from 24 diverse pharmacological groups. The average number of drugs used per individual was 2.97. Analgesics, antibiotics, and gastric acid inhibitors were the most used medications, respectively. 11.6% of the women had a comorbidity, and cardiovascular diseases were the most common. It was determined that 28.3% of women had a serious or moderate DDI. The rate of drugs in categories D and X, which are particularly risky in terms of teratogenicity, was found to be 40.8%. Conclusion: In addition to teratogenic effects, polypharmacy and DDI are also significant risk factors in pregnant women. There is still a crucial need for evidence on the medications prescribed in pregnancy, how it specifically affects women with comorbidities, and related benefits and harms.